Stopped: majority of the participants had exclusion criteria of anticoagulant use
This is a pilot randomized controlled trial (RCT) to gain preliminary evidence regarding the acceptability, tolerability, safety, and efficacy of a combined intervention of Stellate Ganglion Blockade (SGB) and psychoeducation on trauma symptoms and health behaviors in patients exhibiting early PTSD symptoms after cardiac arrest (CA). Primary Aim 1 (Feasibility outcomes): Gain preliminary evidence regarding the acceptability, tolerability, and safety of conducting a randomized trial that evaluates a single SGB treatment in conjunction with psychoeducation among CA patients with early PTSD symptoms. Secondary Aim 1 (Treatment-related outcomes): Test, whether SGB/psychoeducation treatment in CA patients with clinically significant PTSD symptoms is associated with reduced cardiac anxiety, PTSD symptoms, and improved health behaviors (physical activity and sleep duration), assessed objectively by a wrist-worn accelerometer for 4 weeks post-discharge.
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Proportion of Eligible Subjects Who Get Enrolled in the Trial
Timeframe: Baseline (pre-procedure)
Number of Patients Recruited Per Month
Timeframe: Assessed at 10 Month from the beginning of enrollment
Proportion of Participants Who Complete the 4-weeks Assessments
Timeframe: 4 weeks post-enrollment
Proportion of Participants Who Complete the 12-weeks Assessments
Timeframe: 12-weeks post-procedure
Horner's Syndrome
Timeframe: Immediately post-procedure
Treatment Expectancy Eligibility Questionnaire
Timeframe: Immediately post-procedure
The Proportion of Participants Completing the Check-list of Various Components of Psychoeducation
Timeframe: Assessed at baseline post-procedure
Total Actigraph Wear Time
Timeframe: Assessed at 4-weeks post-procedure